LBRXLB Pharmaceuticals Inc

Healthcare
$34.62+116% 1Y

The financials

LB Pharmaceuticals Inc by the numbers

The next results filing is expected around Nov 5, 2026, the same week as a year ago.

LB Pharmaceuticals Inc income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Net income−$52M−$4.9Mn/a
Diluted EPS−$1.71−$13.58n/a

Biotechnology

The closest names by size in the same industry

Compare peers
ANL+9.7%
Adlai Nortye Ltd.
DRTS-1.5%
Alpha Tau Medical Ltd.
LXRX0.00%
Lexicon Pharmaceuticals, Inc.
SPTX-0.39%
Seaport Therapeutics, Inc.
VOR+2.0%
Vor Biopharma Inc.
KURA-1.4%
Kura Oncology, Inc.